| Trial ID: | L0116 |
| Source ID: | NCT01876108
|
| Associated Drug: |
H.pylori eradication
|
| Title: |
The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver|Liver Dysfunction|Insulin Resistance
|
| Interventions: |
Drug: H.pylori eradication (Omeprazole, Amoxicillin, Bismuth subcitrate, Azithromycin)
|
| Outcome Measures: |
Change from baseline liver fat content at 6 months|Change from baseline liver function tests at 6 months
|
| Sponsor/Collaborators: |
Tehran University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
100
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
July 2012
|
| Completion Date: |
July 2013
|
| Results First Posted: |
--
|
| Last Update Posted: |
July 8, 2013
|
| Locations: |
Gastroenterology clinic, Sina Hospital, Tehran, Iran, Islamic Republic of
|
| URL: |
https://ClinicalTrials.gov/show/NCT01876108
|
